Tirzepatide: Breaking Barriers in Weight Management, Type 2 Diabetes, and OSA

Chair: Barbara McGowan (GBR)

14:30 – 14:40Welcome and IntroductionBarbara McGowan (GBR)
14:40 – 14:50The Science Behind TirzepatideTimo Müller (DEU)
14:50 – 15:10Breaking Barriers in Weight Management + DiscussionCarel le Roux (IRL)
15:10 – 15:30Breaking Barriers in Type 2 Diabetes + DiscussionBernhard Ludvik (AUT)
15:30 – 15:55Tirzepatide’s Emerging Role in the Management of Obstructive Sleep Apnea in Patients With Obesity + DiscussionRon Grunstein (AUS)
15:55 – 16:00Closing RemarksBarbara McGowan (GBR)
Lilly logo